Description
Research Studies: Facilitates analysis of FOXO4-p53 interaction inhibition for investigating targeted senolysis Supports investigation into p53-mediated mitochondrial apoptosis in senescent cell assays Enables research on selective elimination of senescent fibroblasts and myofibroblasts Useful for evaluating homeostatic recovery and cellular rejuvenation in aging-related models
RedoxRider –
First vial clung to stopper a little when reconstituted, but swirl fixed it. Please stock 20 mg size next run.
KineticKid –
“FOXO4-DRI” appears as out of stock on mobile even when inventory shows 6—maybe cache issue?
PeptidPanda –
Works great
SynthSeeker –
Works.
ChromKnight –
Bought for senescent‐cell assay; viability drop hit 28 % by day three—matches papers so far.